Skip to main content

NYSE:MDT - Medtronic Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $125.85
  • Forecasted Upside: -0.67 %
  • Number of Analysts: 23
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 19 Buy Ratings
  • 1 Strong Buy Ratings
$126.70
▼ -0.6 (-0.47%)
1 month | 3 months | 12 months
Get New Medtronic Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$125.85
▼ -0.67% Downside Potential
This price target is based on 23 analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $125.85, with a high forecast of $153.00 and a low forecast of $92.00. The average price target represents a -0.67% upside from the last price of $126.70.

Buy

The current consensus among 23 contributing investment analysts is to buy stock in Medtronic. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 17 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/16/2019
  • 0 strong buy ratings
  • 21 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/14/2020
  • 1 strong buy ratings
  • 23 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/14/2020
  • 1 strong buy ratings
  • 25 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/12/2020
  • 1 strong buy ratings
  • 23 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/10/2020
  • 1 strong buy ratings
  • 20 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/8/2021
  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/9/2021
  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/9/2021

Latest Recommendations

  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/21/2021Atlantic SecuritiesInitiated CoverageOverweight$153.00High
i
4/15/2021Atlantic SecuritiesInitiated CoverageOverweight$153.00Medium
i
3/3/2021Raymond JamesBoost Price TargetOutperform$122.00 ➝ $128.00Low
i
3/3/2021Credit Suisse GroupBoost Price TargetOutperform$126.00 ➝ $130.00Low
i
3/2/2021SVB LeerinkBoost Price TargetMarket Perform$123.00 ➝ $129.00Low
i
3/2/2021Stifel NicolausBoost Price TargetBuy$132.00 ➝ $135.00Low
i
2/25/2021Raymond JamesBoost Price TargetOutperform$122.00 ➝ $128.00Low
i
2/25/2021Credit Suisse GroupBoost Price TargetOutperform$126.00 ➝ $130.00Low
i
2/24/2021CowenBoost Price TargetOutperform$120.00 ➝ $135.00Low
i
2/24/2021SVB LeerinkReiterated RatingMarket Perform$123.00 ➝ $129.00Low
i
2/24/2021Stifel NicolausBoost Price TargetBuy$132.00 ➝ $135.00Low
i
12/15/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$100.00 ➝ $119.00Low
i
12/15/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$140.00Low
i
11/25/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$120.00 ➝ $128.00Low
i
11/25/2020TruistBoost Price TargetMarket Perform ➝ Buy$128.00Low
i
11/25/2020Smith Barney CitigroupBoost Price Target$120.00 ➝ $128.00Low
i
11/25/2020UBS GroupBoost Price TargetBuy$123.00 ➝ $130.00Low
i
11/25/2020Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$118.00 ➝ $126.00Low
i
Rating by Matt Miksic at Credit Suisse Group AG
11/25/2020OppenheimerBoost Price TargetOutperform$122.00 ➝ $128.00Low
i
11/25/2020Raymond JamesBoost Price TargetOutperform$115.00 ➝ $122.00Low
i
11/25/2020Morgan StanleyBoost Price TargetEqual Weight$111.00 ➝ $120.00Low
i
11/25/2020Stifel NicolausBoost Price TargetPositive ➝ Buy$125.00 ➝ $132.00Low
i
11/25/2020BTIG ResearchBoost Price TargetBuy$119.00 ➝ $124.00Low
i
11/25/2020SVB LeerinkBoost Price TargetMarket Perform$110.00 ➝ $123.00Low
i
11/24/2020Piper SandlerBoost Price TargetOverweight$120.00 ➝ $130.00Low
i
Rating by Matthew O'Brien at Piper Sandler
11/18/2020Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$118.00 ➝ $127.00Medium
i
10/15/2020Jefferies Financial GroupBoost Price TargetBuy$120.00 ➝ $138.00Low
i
10/8/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
i
Rating by Lee Hambright at Sanford C. Bernstein
10/8/2020Stifel NicolausUpgradeHold ➝ Buy$125.00Low
i
9/11/2020Wolfe ResearchInitiated CoveragePeer Perform$115.00Low
i
8/26/2020BTIG ResearchBoost Price TargetBuy$102.00 ➝ $111.00Low
i
8/26/2020SVB LeerinkBoost Price TargetMarket Perform$105.00 ➝ $110.00Low
i
8/26/2020Morgan StanleyBoost Price TargetEqual Weight$106.00 ➝ $111.00Low
i
8/26/2020Credit Suisse GroupBoost Price TargetOutperform$117.00 ➝ $118.00Low
i
Rating by Matt Miksic at Credit Suisse Group AG
8/26/2020Raymond JamesBoost Price TargetOutperform$107.00 ➝ $115.00Medium
i
8/26/2020CitigroupBoost Price TargetBuy$108.00 ➝ $120.00Low
i
8/25/2020OppenheimerReiterated RatingBuy$112.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/25/2020Needham & Company LLCBoost Price TargetBuy$113.00 ➝ $124.00Low
i
Rating by Michael Matson at Needham & Company LLC
8/18/2020CowenReiterated RatingBuy$110.00Low
i
Rating by Josh Jennings at Cowen Inc
8/11/2020Piper SandlerReiterated RatingBuy$120.00Medium
i
Rating by Matthew O'Brien at Piper Sandler
7/15/2020Needham & Company LLCReiterated RatingBuy$113.00Low
i
Rating by Michael Matson at Needham & Company LLC
7/2/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
i
Rating by Matt Miksic at Credit Suisse Group AG
5/27/2020SunTrust BanksLower Price Target$130.00 ➝ $105.00Medium
i
Rating by Kaila Krum at SunTrust Banks, Inc.
5/23/2020CSFBReiterated RatingBuy$117.00N/A
i
5/22/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
i
Rating by Matt Miksic at Credit Suisse Group AG
5/22/2020Bank of AmericaReiterated RatingBuy$130.00N/A
i
Rating by Bob Hopkins at Bank of America Co.
5/22/2020Jefferies Financial GroupBoost Price TargetBuy$110.00 ➝ $120.00Medium
i
5/22/2020OppenheimerLower Price TargetOutperform$131.00 ➝ $112.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/22/2020UBS GroupLower Price TargetBuy$130.00 ➝ $118.00Medium
i
5/22/2020Morgan StanleyLower Price TargetEqual Weight$112.00 ➝ $106.00Medium
i
5/22/2020Raymond JamesLower Price TargetOutperform$110.00 ➝ $107.00Medium
i
5/22/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$123.00 ➝ $118.00Medium
i
5/21/2020OppenheimerInitiated CoverageBuy$131.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/21/2020Needham & Company LLCReiterated RatingBuy$113.00Low
i
Rating by Michael Matson at Needham & Company LLC
5/21/2020Piper SandlerLower Price TargetOverweight$135.00 ➝ $120.00Low
i
Rating by Matthew O'Brien at Piper Sandler
5/21/2020CfraUpgradeBuy ➝ Strong-Buy$127.00 ➝ $121.00Low
i
5/14/2020DZ BankDowngradeBuy ➝ Hold$92.00Low
i
4/28/2020SVB LeerinkBoost Price TargetMarket Perform$100.00 ➝ $105.00Medium
i
4/23/2020Sanford C. BernsteinReiterated RatingHold$112.00Medium
i
Rating by Lee Hambright at Sanford C. Bernstein
4/22/2020Needham & Company LLCReiterated RatingBuy$109.00Low
i
Rating by Michael Matson at Needham & Company LLC
4/22/2020Wells Fargo & CompanyLower Price TargetOverweight$130.00 ➝ $108.00High
i
4/9/2020JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 ➝ $115.00Medium
i
4/9/2020Raymond JamesLower Price TargetOutperform$122.00 ➝ $110.00Medium
i
3/30/2020SunTrust BanksReiterated RatingBuy$130.00High
i
Rating by Kaila Krum at SunTrust Banks, Inc.
3/30/2020BTIG ResearchLower Price TargetHold ➝ Buy$124.00 ➝ $102.00Low
i
3/30/2020Needham & Company LLCDowngradeStrong-Buy ➝ Buy$134.00 ➝ $109.00Low
i
3/27/2020Morgan StanleyLower Price TargetEqual Weight$123.00 ➝ $112.00Low
i
3/27/2020CitigroupLower Price TargetBuy$124.00 ➝ $105.00Low
i
3/25/2020DZ BankUpgradeHold ➝ Buy$90.00High
i
3/6/2020Credit Suisse GroupLower Price TargetOutperform$126.00 ➝ $121.00Low
i
3/4/2020CitigroupInitiated CoverageBuy$124.00Medium
i
2/19/2020Raymond JamesBoost Price TargetOutperform$121.00 ➝ $122.00Low
i
2/19/2020BTIG ResearchLower Price TargetBuy$126.00 ➝ $124.00Low
i
2/18/2020Piper SandlerReiterated RatingBuy$135.00Low
i
Rating by Matthew O'Brien at Piper Sandler
2/18/2020CfraBoost Price TargetBuy$126.00 ➝ $127.00Medium
i
2/17/2020Credit Suisse GroupReiterated RatingBuy$126.00High
i
2/12/2020The Goldman Sachs GroupInitiated CoverageSell$118.00Medium
i
1/22/2020Piper SandlerBoost Price TargetOverweight$125.00 ➝ $135.00Low
i
1/16/2020UBS GroupBoost Price TargetBuy$127.00 ➝ $130.00Medium
i
Rating by Matthew Taylor at UBS Group AG
1/7/2020SunTrust BanksInitiated CoverageBuy$130.00High
i
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$99.00Low
i
Rating by Pito Chickering at Deutsche Bank Aktiengesellschaft
1/2/2020CitigroupDowngradeBuy ➝ NeutralMedium
i
1/2/2020GuggenheimUpgradeNeutral ➝ Buy$135.00Low
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$122.00 ➝ $128.00Low
i
12/17/2019Morgan StanleyBoost Price TargetEqual Weight$116.00 ➝ $123.00Low
i
Rating by David Lewis at Morgan Stanley
11/25/2019ArgusBoost Price TargetBuy$135.00Low
i
11/20/2019Royal Bank of CanadaBoost Price TargetOutperform$118.00 ➝ $122.00Medium
i
Rating by Glenn Novarro at Royal Bank of Canada
11/20/2019OppenheimerBoost Price TargetOutperform$118.00 ➝ $123.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/20/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$118.00 ➝ $123.00Low
i
Rating by Pito Chickering at Deutsche Bank Aktiengesellschaft
11/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$125.00Low
i
8/28/2019Needham & Company LLCReiterated RatingBuy$133.00Low
i
8/21/2019Bank of AmericaSet Price TargetBuy$118.00Medium
i
Rating by Bob Hopkins at Bank of America Co.
8/21/2019OppenheimerBoost Price TargetOutperform$110.00 ➝ $118.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/21/2019BMO Capital MarketsBoost Price TargetOutperform$107.00 ➝ $118.00Low
i
8/21/2019BarclaysBoost Price TargetOverweight$110.00 ➝ $117.00Low
i
Rating by Kristen Stewart at Barclays PLC
8/21/2019Morgan StanleyBoost Price TargetEqual Weight$105.00 ➝ $111.00Low
i
8/21/2019UBS GroupBoost Price TargetOverweight ➝ Buy$112.00 ➝ $122.00Low
i
8/21/2019Raymond JamesBoost Price TargetOutperform$105.00 ➝ $118.00Low
i
8/21/2019Wells Fargo & CompanyBoost Price TargetOutperform$110.00 ➝ $120.00Low
i
8/21/2019Stifel NicolausBoost Price TargetHold$95.00 ➝ $112.00Low
i
8/21/2019BTIG ResearchBoost Price TargetBuy$120.00Low
i
8/21/2019Northland SecuritiesReiterated RatingHold$100.00Low
i
8/19/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$100.00 ➝ $111.00Low
i
8/16/2019Royal Bank of CanadaSet Price TargetBuy$110.00Low
i
8/14/2019Morgan StanleyBoost Price TargetEqual Weight$100.00 ➝ $105.00Low
i
8/14/2019CowenReiterated RatingOutperform$99.00 ➝ $111.00Medium
i
7/23/2019Needham & Company LLCReiterated RatingBuyLow
i
7/15/2019OppenheimerSet Price TargetBuy$110.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
7/11/2019BarclaysBoost Price TargetOverweight$104.00 ➝ $110.00Low
i
6/20/2019Northland SecuritiesReiterated RatingHold$100.00Low
i
6/14/2019UBS GroupBoost Price TargetBuy$112.00Low
i
6/4/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$100.00 ➝ $110.00Medium
i
5/28/2019Royal Bank of CanadaLower Price TargetOutperform$100.00Medium
i
5/27/2019Needham & Company LLCReiterated RatingBuy$121.00Medium
i
4/4/2019Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$101.00 ➝ $100.00Low
i
3/18/2019Northland SecuritiesReiterated RatingHold$84.00Low
i
2/25/2019CitigroupBoost Price TargetNeutral ➝ Neutral$95.00 ➝ $101.00Low
i
2/20/2019BarclaysReiterated RatingBuy$104.00Low
i
Rating by Kristen Stewart at Barclays PLC
2/20/2019OppenheimerSet Price TargetBuy$104.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/4/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$120.00 ➝ $117.00Low
i
1/15/2019BTIG ResearchUpgradeNeutral ➝ Buy$100.00Low
i
1/8/2019BarclaysLower Price TargetOverweight ➝ Overweight$113.00 ➝ $104.00Low
i
Rating by Kristen Stewart at Barclays PLC
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$99.00High
i
1/2/2019Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$98.00 ➝ $102.00Low
i
1/2/2019CitigroupDowngradeBuy ➝ Neutral$109.00 ➝ $96.00Medium
i
12/19/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00 ➝ $109.00High
i
12/17/2018Credit Suisse GroupInitiated CoverageBuy ➝ Outperform$109.00 ➝ $109.00Low
i
11/28/2018UBS GroupInitiated CoverageBuy ➝ Buy$112.00Medium
i
11/21/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$105.00 ➝ $104.00Medium
i
11/20/2018OppenheimerReiterated RatingBuy$104.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
10/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$113.00Medium
i
Rating by Kristen Stewart at Barclays PLC
10/8/2018ArgusBoost Price TargetBuy ➝ Buy$108.00 ➝ $120.00Medium
i
10/3/2018Royal Bank of CanadaBoost Price TargetOutperform$109.00Low
i
9/21/2018OppenheimerReiterated RatingBuyMedium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/27/2018ArgusBoost Price TargetBuy ➝ Buy$95.00 ➝ $108.00Low
i
8/24/2018SunTrust BanksBoost Price TargetBuy$110.00Low
i
8/24/2018CitigroupBoost Price TargetBuy ➝ Buy$104.00 ➝ $109.00Low
i
8/22/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$98.00 ➝ $105.00Low
i
8/22/2018SVB LeerinkBoost Price TargetMarket Perform$95.00 ➝ $100.00Low
i
8/22/2018Royal Bank of CanadaBoost Price TargetOutperform$104.00Low
i
8/22/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$94.00 ➝ $104.00Low
i
8/22/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$95.00 ➝ $101.00Low
i
8/22/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $105.00Low
i
8/22/2018Stifel NicolausBoost Price TargetHold ➝ Hold$87.00 ➝ $96.00Low
i
8/21/2018OppenheimerReiterated RatingBuy$104.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/13/2018Needham & Company LLCUpgradeBuy ➝ Strong-Buy$103.00 ➝ $119.00Low
i
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$88.00Medium
i
6/6/2018William BlairInitiated CoverageOutperform ➝ Market PerformLow
i
Rating by M. Kaczor at William Blair
6/6/2018OppenheimerSet Price TargetBuy$96.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
6/6/2018Needham & Company LLCBoost Price TargetBuy$97.00 ➝ $103.00Low
i
5/31/2018Raymond JamesInitiated CoverageOutperform$96.00Low
i
5/25/2018Piper Jaffray CompaniesBoost Price TargetOverweight$96.00Low
i
5/25/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$90.00 ➝ $95.00Low
i
5/24/2018OppenheimerReiterated RatingBuy$96.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/21/2018SunTrust BanksBoost Price TargetBuy$96.00Low
i
4/27/2018Piper Jaffray CompaniesInitiated CoverageOverweight$90.00Medium
i
3/29/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $90.00Medium
i
3/20/2018OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/22/2018CitigroupReiterated RatingBuy ➝ Buy$100.00 ➝ $93.00Low
i
2/20/2018OppenheimerReiterated RatingBuy$94.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/14/2018Royal Bank of CanadaReiterated RatingOutperform$92.00Medium
i
2/5/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$91.00 ➝ $95.00High
i
1/19/2018OppenheimerSet Price TargetBuy$94.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$92.50High
i
1/2/2018Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
12/21/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
12/12/2017ArgusUpgradeHold ➝ Buy$81.27 ➝ $95.00Low
i
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$94.00Low
i
11/23/2017Jefferies Financial GroupReiterated RatingBuy$99.00N/A
i
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/A
i
11/22/2017OppenheimerReiterated RatingBuy$94.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/22/2017Stifel NicolausBoost Price TargetHold$83.00 ➝ $85.00N/A
i
11/19/2017SunTrust BanksSet Price TargetBuy$92.00N/A
i
Rating by Bruce Nudell at SunTrust Banks, Inc.
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/A
i
11/3/2017SunTrust BanksReiterated RatingBuy$96.00N/A
i
11/3/2017CowenReiterated RatingBuy$95.00N/A
i
Rating by Josh Jennings at Cowen Inc
10/10/2017BMO Capital MarketsReiterated RatingOutperform$92.00 ➝ $89.00N/A
i
10/10/2017Needham & Company LLCLower Price TargetBuy$95.00 ➝ $94.00N/A
i
10/9/2017SVB LeerinkReiterated RatingMarket Perform$88.00 ➝ $85.00N/A
i
10/9/2017Stifel NicolausLower Price TargetHold$91.00 ➝ $83.00N/A
i
10/9/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$90.00 ➝ $85.00N/A
i
10/9/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$93.00 ➝ $83.00N/A
i
10/2/2017SunTrust BanksReiterated RatingBuy$96.00Low
i
9/28/2017Jefferies Financial GroupReiterated RatingBuy$96.00Low
i
8/24/2017UBS GroupReiterated RatingOverweightLow
i
8/23/2017Jefferies Financial GroupLower Price TargetBuy$103.00 ➝ $96.00Low
i
8/23/2017BarclaysLower Price TargetOverweight$94.00 ➝ $92.00Low
i
8/23/2017BMO Capital MarketsReiterated RatingOutperform$94.00 ➝ $92.00Low
i
8/22/2017CowenSet Price TargetBuy$95.00Low
i
Rating by Josh Jennings at Cowen Inc
8/22/2017OppenheimerReiterated RatingBuy$92.00Medium
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/21/2017Royal Bank of CanadaReiterated RatingBuy$90.00Low
i
8/3/2017Jefferies Financial GroupReiterated RatingBuy$103.00Low
i
7/31/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$96.00Low
i
Rating by Brittany Henderson at Deutsche Bank Aktiengesellschaft
7/18/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
7/12/2017Wells Fargo & CompanyReiterated RatingOutperformLow
i
7/6/2017William BlairReiterated RatingOutperformMedium
i
Rating by K. Krum at William Blair
5/30/2017BMO Capital MarketsBoost Price TargetOutperform$87.00 ➝ $94.00Low
i
5/30/2017UBS GroupReiterated RatingBuy$94.00 ➝ $95.00N/A
i
5/30/2017Morgan StanleyBoost Price TargetEqual Weight$84.00 ➝ $86.00Low
i
Rating by David Lewis at Morgan Stanley
5/28/2017BarclaysReiterated RatingOverweight$92.00 ➝ $94.00Low
i
5/28/2017CowenReiterated RatingOutperform$86.00 ➝ $95.00Low
i
5/28/2017Stifel NicolausReiterated RatingHold$84.00 ➝ $91.00Low
i
5/28/2017Evercore ISIReiterated RatingOutperform$88.50 ➝ $91.00Low
i
5/26/2017CIBCReiterated RatingBuyLow
i
5/25/2017Needham & Company LLCReiterated RatingBuy ➝ Buy$91.00 ➝ $95.00Low
i
5/25/2017OppenheimerReiterated RatingBuy$87.00 ➝ $93.00Low
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/16/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$87.00Low
i
4/20/2017Northland SecuritiesReiterated RatingHold$80.00Medium
i
4/19/2017Evercore ISIBoost Price TargetOutperform$88.00 ➝ $88.50Medium
i
4/18/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
4/18/2017Royal Bank of CanadaReiterated RatingBuy$85.00Low
i
3/27/2017Needham & Company LLCReiterated RatingBuy$91.00Low
i
3/22/2017OppenheimerReiterated RatingBuyLow
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
3/20/2017BTIG ResearchReiterated RatingNeutralLow
i
2/23/2017OppenheimerReiterated RatingOutperform$84.00 ➝ $87.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/23/2017SVB LeerinkBoost Price TargetMarket Perform$80.00 ➝ $85.00N/A
i
2/22/2017WedbushReiterated RatingNeutral$85.00N/A
i
2/21/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$84.00 ➝ $91.00N/A
i
2/21/2017Evercore ISIBoost Price TargetBuy$78.00 ➝ $88.00N/A
i
2/17/2017UBS GroupBoost Price TargetBuy$88.00 ➝ $94.00N/A
i
Rating by steven fisher at UBS Group AG
2/17/2017Jefferies Financial GroupReiterated RatingBuy$88.00N/A
i
2/6/2017Needham & Company LLCReiterated RatingBuy$84.00N/A
i
1/8/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$96.00N/A
i
Rating by Kristen Stewart at Deutsche Bank Aktiengesellschaft
1/3/2017Morgan StanleyReiterated RatingEqual Weight ➝ OverweightN/A
i
1/3/2017Bank of AmericaDowngradeBuy ➝ Neutral$78.00N/A
i
1/3/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$85.00 ➝ $77.00N/A
i
1/3/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$84.00 ➝ $79.00N/A
i
11/28/2016Evercore ISIReiterated RatingBuy$94.00 ➝ $80.00N/A
i
Rating by Vijay Kumar at Evercore ISI
11/23/2016OppenheimerLower Price TargetOutperform$94.00 ➝ $84.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/23/2016Jefferies Financial GroupLower Price TargetBuy$100.00 ➝ $88.00N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
11/23/2016BarclaysLower Price TargetOverweight$93.00 ➝ $85.00N/A
i
11/23/2016BMO Capital MarketsLower Price TargetOutperform$94.00 ➝ $87.00N/A
i
Rating by Joanne Wuensch at BMO Capital Markets
11/23/2016Stifel NicolausLower Price TargetHold$91.00 ➝ $81.00N/A
i
11/22/2016OppenheimerSet Price TargetBuy$94.00N/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/22/2016Needham & Company LLCReiterated RatingBuy$95.00 ➝ $84.00N/A
i
Rating by Michael Matson at Needham & Company LLC
10/31/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
9/22/2016UBS GroupReiterated RatingBuy$96.00N/A
i
Rating by steven fisher at UBS Group AG
8/29/2016UBS GroupReiterated RatingBuy$92.00 ➝ $96.00N/A
i
Rating by steven fisher at UBS Group AG
8/25/2016Needham & Company LLCBoost Price TargetBuy$93.00 ➝ $95.00N/A
i
Rating by Michael Matson at Needham & Company LLC
8/25/2016Credit Suisse GroupReiterated RatingOutperform$92.00N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
8/25/2016Jefferies Financial GroupReiterated RatingBuy$93.00N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
8/23/2016CowenSet Price TargetBuy$94.00N/A
i
Rating by josh jennings at Cowen Inc
8/23/2016CitigroupInitiated CoverageBuy$102.00N/A
i
8/22/2016UBS GroupReiterated RatingBuy$92.00 ➝ $96.00N/A
i
Rating by Matt Miksic at UBS Group AG
7/15/2016UBS GroupReiterated RatingBuy$92.00N/A
i
Rating by Matt Miksic at UBS Group AG
7/6/2016The Goldman Sachs GroupReiterated RatingBuyN/A
i
6/29/2016UBS GroupReiterated RatingBuy$92.00N/A
i
Rating by Matt Miksic at UBS Group AG
6/28/2016Credit Suisse GroupReiterated RatingBuy$85.00N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
6/27/2016Evercore ISIReiterated RatingBuy$86.50N/A
i
Rating by Vijay Kumar at Evercore ISI
6/27/2016Needham & Company LLCReiterated RatingBuyN/A
i
Rating by Benji Star at Needham & Company LLC
6/27/2016BTIG ResearchReiterated RatingHoldN/A
i
Rating by Sean Lavin at BTIG Research
6/20/2016ArgusReiterated RatingHold ➝ HoldN/A
i
6/15/2016Piper Jaffray CompaniesReiterated RatingOverweight$93.00 ➝ $94.00N/A
i
6/15/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$90.00N/A
i
Rating by Kristen Stewart at Deutsche Bank Aktiengesellschaft
6/13/2016SunTrust BanksBoost Price TargetBuy$93.00 ➝ $98.00N/A
i
6/8/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Matt Miksic at UBS Group AG
6/8/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
6/8/2016GuggenheimInitiated CoverageNeutralN/A
i
6/7/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
6/7/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
6/7/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by David Lewis at Morgan Stanley
6/7/2016BMO Capital MarketsReiterated RatingBuyN/A
i
Rating by Joanne Wuensch at BMO Capital Markets
6/7/2016BTIG ResearchReiterated RatingHoldN/A
i
Rating by Sean Lavin at BTIG Research
6/7/2016Needham & Company LLCReiterated RatingBuy$90.00 ➝ $93.00N/A
i
Rating by Michael Matson at Needham & Company LLC
6/4/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Bob Hopkins at Bank of America Co.
6/2/2016WedbushReiterated RatingHoldN/A
i
Rating by Tao Levy at Wedbush
6/2/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$90.00 ➝ $92.00N/A
i
Rating by Kristen Stewart at Deutsche Bank Aktiengesellschaft
6/1/2016SVB LeerinkReiterated RatingHold$82.00 ➝ $85.00N/A
i
Rating by Danielle Antalffy at SVB Leerink LLC
6/1/2016Morgan StanleyReiterated RatingBuy$89.00N/A
i
Rating by David Lewis at Morgan Stanley
6/1/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by Glenn Novarro at Royal Bank of Canada
6/1/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Sharon Stein at UBS Group AG
6/1/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
6/1/2016WedbushBoost Price TargetNeutral$79.00 ➝ $82.00N/A
i
6/1/2016BTIG ResearchDowngradeBuy ➝ Neutral$82.00N/A
i
6/1/2016Piper Jaffray CompaniesReiterated RatingIn-Line$85.00 ➝ $93.00N/A
i
5/31/2016Needham & Company LLCReiterated RatingBuy$90.00 ➝ $93.00N/A
i
Rating by Michael Matson at Needham & Company LLC
5/31/2016BTIG ResearchDowngradeBuy ➝ Neutral$82.00N/A
i
Rating by Sean Lavin at BTIG Research
5/31/2016Credit Suisse GroupReiterated RatingBuy$85.00N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
5/31/2016BMO Capital MarketsReiterated RatingBuy$87.00N/A
i
Rating by Joanne Wuensch at BMO Capital Markets
5/26/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/22/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Bob Hopkins at Bank of America Co.
5/19/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Bruce Nudell at Credit Suisse Group AG
5/14/2016Royal Bank of CanadaReiterated RatingOutperform$87.00N/A
i
(Data available from 5/9/2016 forward)
Medtronic logo
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $126.70
$126.52
$128.44

50 Day Range

MA: $123.54
$115.03
$131.50

52 Week Range

Now: $126.70
$87.68
$132.30

Volume

3,871,140 shs

Average Volume

4,645,956 shs

Market Capitalization

$170.80 billion

P/E Ratio

48.36

Dividend Yield

1.82%

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of Medtronic?

The following sell-side analysts have issued research reports on Medtronic in the last year: Atlantic Securities, Bank of America Co., BTIG Research, Cfra, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, CSFB, Deutsche Bank Aktiengesellschaft, DZ Bank AG, Jefferies Financial Group Inc., Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Sanford C. Bernstein, Smith Barney Citigroup, Stifel Nicolaus, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, UBS Group AG, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for MDT.

What is the current price target for Medtronic?

26 Wall Street analysts have set twelve-month price targets for Medtronic in the last year. Their average twelve-month price target is $125.85, suggesting a possible downside of 0.7%. Atlantic Securities has the highest price target set, predicting MDT will reach $153.00 in the next twelve months. DZ Bank AG has the lowest price target set, forecasting a price of $92.00 for Medtronic in the next year.
View the latest price targets for MDT.

What is the current consensus analyst rating for Medtronic?

Medtronic currently has 3 hold ratings, 19 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDT will outperform the market and that investors should add to their positions of Medtronic.
View the latest ratings for MDT.

What other companies compete with Medtronic?

How do I contact Medtronic's investor relations team?

Medtronic's physical mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company's listed phone number is 353-1438-1700 and its investor relations email address is [email protected] The official website for Medtronic is www.medtronic.com.